
### [MONDO:0020376](http://purl.obolibrary.org/obo/MONDO_0020376)
**Label:** early-onset nuclear cataract

**Subclasses:** [MONDO:0012395](http://purl.obolibrary.org/obo/MONDO_0012395) (cataract 18), [MONDO:0012260](http://purl.obolibrary.org/obo/MONDO_0012260) (cataract 35), [MONDO:0011808](http://purl.obolibrary.org/obo/MONDO_0011808) (cataract 27), [MONDO:0007287](http://purl.obolibrary.org/obo/MONDO_0007287) (cataract 41), 

**Mapped go classes:** [GO:0055074](http://purl.obolibrary.org/obo/GO_0055074) (calcium ion homeostasis), [GO:0061077](http://purl.obolibrary.org/obo/GO_0061077) (chaperone-mediated protein folding), [GO:0005770](http://purl.obolibrary.org/obo/GO_0005770) (late endosome), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0005776](http://purl.obolibrary.org/obo/GO_0005776) (autophagosome), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0072383](http://purl.obolibrary.org/obo/GO_0072383) (plus-end-directed vesicle transport along microtubule), [GO:0044183](http://purl.obolibrary.org/obo/GO_0044183) (protein binding involved in protein folding), [GO:0005768](http://purl.obolibrary.org/obo/GO_0005768) (endosome), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:1901098](http://purl.obolibrary.org/obo/GO_1901098) (positive regulation of autophagosome maturation), [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0000502](http://purl.obolibrary.org/obo/GO_0000502) (proteasome complex), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0006458](http://purl.obolibrary.org/obo/GO_0006458) ('de novo' protein folding), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), 

**Class expressions from DL-Learner:**

- [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration) 56.25%
- [GO:0051082](http://purl.obolibrary.org/obo/GO_0051082) (unfolded protein binding) 56.25%
- [GO:0044183](http://purl.obolibrary.org/obo/GO_0044183) (protein binding involved in protein folding) 56.25%
- [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development) 56.25%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 56.25%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 56.25%
- [GO:0003323](http://purl.obolibrary.org/obo/GO_0003323) (type B pancreatic cell development) 56.25%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 56.25%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 56.25%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 56.25%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 56.25%


